The UK Ministry of Health will review official data on the side effects and safety of the popular antidepressant seroxate and other drugs in its group, the Financial Times reported.. In the instructions to the drug, in particular, there will be information that he is able to cause drug dependence, reports BBC.

Now patients who are discharged seroksat will be advised to continue treatment until the drug is canceled by the doctor. This is due to the danger of developing serious complications caused by a sudden withdrawal of the drug. It is expected that manufacturers of antidepressants and first of all GlaxoSmithKline, which owns the trade mark "Seroksat", will suffer from this revision.. Representatives of GlaxoSmithKline reported that a discussion arose between the company and the Agency for the Use of Medicines and Health Products (Medicines and Healthcare Products Regulatory Agency) about "planned changes in the description of seroxate". The new side effects of antidepressants became known last year from the BBC Panorama program.

After the release of the report, patients taking antidepressants and their families reported 16 cases of suicide, 47 attempts at suicide and 92 cases of aggressive behavior against a background of drug therapy with seroxate and its analogues, for example - Prozac. The manufacturer of seroxate GlaxoSmithKline still calls the drug "a well-tolerated drug widely used by doctors around the world for more than 10 years". According to the Financial Times, annually sales of serotax in Britain alone bring GSK more than 100 million pounds sterling.

medicus. en.

Keywords:.